1. Home
  2. CAH

as 05-20-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Health Care

Other Pharmaceuticals

Nasdaq

Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and McKesson, the three comprise well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

Founded: 1979 Country:
United States
United States
Employees: N/A City: DUBLIN
Market Cap: 24.2B IPO Year: N/A
Target Price: $107.14 AVG Volume (30 days): 2.2M
Analyst Decision: Buy Number of Analysts: 14
Dividend Yield: 2.06% Dividend Payout Frequency: Quarterly
EPS: 2.27 EPS Growth: 32.75
52 Week Low/High: $80.90 - $116.04 Next Earning Date: 05-02-2024
Revenue: $220,572,000,000 Revenue Growth: 11.03%
Revenue Growth (this year): 11.81% Revenue Growth (next year): 8.47%

Share on Social Networks:

Stock Insider Trading Activity of Cardinal Health Inc. (CAH)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
WEITZMAN DEBORAH CAH CEO, Pharmaceutical Segment Nov 27 '23 Sell $106.31 36,642 $3,895,411.02 35,202 SEC Form 4